 |
If the trial studies one or more U.S. FDA-regulated drug or biologic products (a drug subject to section 505 of the Federal Food, Drug, and Cosmetic Act or a biological product subject to section 351 of the Public Health Service Act), select Yes. Otherwise, select No.
Accessibility
| Contact CBIIT | FOIA | HHS Vulnerability Disclosure | Comment Policy
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH ... Turning Discovery Into Health®
Powered by Atlassian Confluence, themed by RefinedTheme